SANDOZ FESOTERODINE FUMARATE

Sandoz Canada, Inc.🇨🇦 Health Canada

Approval Id: 71049669bda7d763
Drug Approval Canada Name: SANDOZ FESOTERODINE FUMARATE
Product Name: SANDOZ FESOTERODINE FUMARATE
Status: Marketed
Status Date: 2022-05-02
Original Market Date: 2022-05-02
Din: 02521768
Drug Class: Human
Dosage Form: Tablet (Extended-Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 86:12.04
Atc Original: G04BD11 FESOTERODINE
Atc Name: g 04 bd 11
Aig Number: 0153091001
Company Name: Sandoz Canada, Inc.
Company Address: 4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path: /organization/sandoz-canada-inc

FESOTERODINE FUMARATE

4 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

71049669bda7d763

Type

Standard